SCHEMBL10576187

SCHEMBL10576187

CCC(C)(NC(C)=O)c1ccc2[nH]c(-c3ccc(C)cc3)nc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPBWR1 P48145 1/20 0.46
▸ HDAC6 Q9UBN7 3/20 0.45
▸ EGFR P00533 1/20 0.44
▸ CHEK2 O96017 4/20 0.44
▸ HPSE Q9Y251 2/20 0.43
▸ MMP2 P08253 1/20 0.41
▸ MMP9 P14780 1/20 0.41
▸ MMP8 P22894 1/20 0.41
▸ MMP13 P45452 1/20 0.41
▸ MAPT P10636 3/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ ADRB2 P07550 1/20 0.41
▸ HDAC3 O15379 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ KDR P35968 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10578757 0.89 KDM4E (0.50) HDAC6MAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL10574927 0.84 PDE2A (0.50) MAPTALDH1A1SMN1; SMN2RAB9AHPGD
SCHEMBL10576178 0.81 NPBWR1 (0.46) NPBWR1HDAC6EGFRCHEK2HPSE
SCHEMBL10575172 0.80 PDE2A (0.35) HDAC6MAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL10574195 0.78 PKN1 (0.43) HDAC6MAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL10695060 0.75 NPC1 (0.40) HDAC6CHEK2HPSEMAPTALDH1A1
SCHEMBL10577465 0.74 NPBWR1 (0.53) NPBWR1HDAC6EGFRCHEK2MMP2
SCHEMBL10574665 0.73 NPBWR1 (0.47) NPBWR1HDAC6EGFRCHEK2HPSE
SCHEMBL10576194 0.72 NPBWR1 (0.58) NPBWR1HDAC6EGFRCHEK2HPSE
SCHEMBL21705321 0.72 HDAC6 (0.66) NPBWR1HDAC6CHEK2HPSEMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4882342-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-11-21 — — US disclosed
EP-0266558-A2 5-Alkylbenzimidazoles, process for their preparation and medicaments containing them Roche Diagnostics GmbH (DE) 1988-05-11 — — EP disclosed
Send feedback